 | • レポートコード：QYR2104Z3942 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ムコソルバン（アンブロキソール）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、カプセル、注射剤、溶液、シロップ、顆粒）、用途別市場規模（急性・慢性気管支炎、気管支喘息、気管支拡張症、肺気腫、結核（TB）、じん肺、術後投薬、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ムコソルバン（アンブロキソール）の市場動向 ・企業の競争状況、市場シェア ・ムコソルバン（アンブロキソール）の種類別市場規模（錠剤、カプセル、注射剤、溶液、シロップ、顆粒） ・ムコソルバン（アンブロキソール）の用途別市場規模（急性・慢性気管支炎、気管支喘息、気管支拡張症、肺気腫、結核（TB）、じん肺、術後投薬、その他） ・ムコソルバン（アンブロキソール）の北米市場規模2016-2027（アメリカ、カナダ） ・ムコソルバン（アンブロキソール）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ムコソルバン（アンブロキソール）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ムコソルバン（アンブロキソール）の中南米市場規模2016-2027（メキシコ、ブラジル） ・ムコソルバン（アンブロキソール）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Zywie LLC、Sanofi、Hanmi、Adare Pharma、Boehringer Ingelheim、Teijin、Astellas Pharma、Chiesi、Sidus、Takeda、Euderma、Changzhou Siyao Pharmaceuticals、Shandong Fangming Pharmaceutical Group、TIPR Pharmaceutical、Hainan Weikang Pharmaceutical、Sandoz (Novartis)、Sinopharm、Jiangsu Hengrui Pharmaceutical、Yantai Dongcheng Dayang Pharmaceutical、Zhuhai Tongyuan Pharmaceutical、Beijing Taiyang Pharmaceutical、Nanjing Yihua Pharmaceutical、Shandong Luoxin Pharmaceutical Group、Shandong Yuxin Pharmaceutical、CSPC、Shanxi Qianyuan Pharmaceutical Group、Yangtze Pharmaceutical Group、Jiangsu Aosaikang Pharmaceutical、Jiangsu Haosen Pharmaceutical Group、Shenyang Xinma Pharmaceutical） ・結論 |
Ambroxol is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It is the active ingredient of Mucosolvan, Lasolvan or Mucoangin. The substance is a mucoactive drug with several properties including secretolytic and secretomotoric actions that restore the physiological clearance mechanisms of the respiratory tract which play an important role in the body’s natural defence mechanisms. It stimulates synthesis and release of surfactant by type II pneumocytes. Surfactants acts as an anti-glue factor by reducing the adhesion of mucus to the bronchial wall, in improving its transport and in providing protection against infection and irritating agents.
Market Analysis and Insights: Global Mucosolvan (Ambroxol) Market
The global Mucosolvan (Ambroxol) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mucosolvan (Ambroxol) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mucosolvan (Ambroxol) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mucosolvan (Ambroxol) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mucosolvan (Ambroxol) market.
Global Mucosolvan (Ambroxol) Scope and Market Size
Mucosolvan (Ambroxol) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mucosolvan (Ambroxol) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tablets
Capsules
Injections
Solutions
Syrups
Granules
Segment by Application
Acute And Chronic Bronchitis
Bronchial Asthma
Bronchiectasis
Emphysema
Tuberculosis (TB)
Pneumoconiosis
Postoperative Medication
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Zywie LLC
Sanofi
Hanmi
Adare Pharma
Boehringer Ingelheim
Teijin
Astellas Pharma
Chiesi
Sidus
Takeda
Euderma
Changzhou Siyao Pharmaceuticals
Shandong Fangming Pharmaceutical Group
TIPR Pharmaceutical
Hainan Weikang Pharmaceutical
Sandoz (Novartis)
Sinopharm
Jiangsu Hengrui Pharmaceutical
Yantai Dongcheng Dayang Pharmaceutical
Zhuhai Tongyuan Pharmaceutical
Beijing Taiyang Pharmaceutical
Nanjing Yihua Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Shandong Yuxin Pharmaceutical
CSPC
Shanxi Qianyuan Pharmaceutical Group
Yangtze Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mucosolvan (Ambroxol) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Injections
1.2.5 Solutions
1.2.6 Syrups
1.2.7 Granules
1.3 Market by Application
1.3.1 Global Mucosolvan (Ambroxol) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute And Chronic Bronchitis
1.3.3 Bronchial Asthma
1.3.4 Bronchiectasis
1.3.5 Emphysema
1.3.6 Tuberculosis (TB)
1.3.7 Pneumoconiosis
1.3.8 Postoperative Medication
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mucosolvan (Ambroxol) Market Perspective (2016-2027)
2.2 Mucosolvan (Ambroxol) Growth Trends by Regions
2.2.1 Mucosolvan (Ambroxol) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mucosolvan (Ambroxol) Historic Market Share by Regions (2016-2021)
2.2.3 Mucosolvan (Ambroxol) Forecasted Market Size by Regions (2022-2027)
2.3 Mucosolvan (Ambroxol) Industry Dynamic
2.3.1 Mucosolvan (Ambroxol) Market Trends
2.3.2 Mucosolvan (Ambroxol) Market Drivers
2.3.3 Mucosolvan (Ambroxol) Market Challenges
2.3.4 Mucosolvan (Ambroxol) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mucosolvan (Ambroxol) Players by Revenue
3.1.1 Global Top Mucosolvan (Ambroxol) Players by Revenue (2016-2021)
3.1.2 Global Mucosolvan (Ambroxol) Revenue Market Share by Players (2016-2021)
3.2 Global Mucosolvan (Ambroxol) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mucosolvan (Ambroxol) Revenue
3.4 Global Mucosolvan (Ambroxol) Market Concentration Ratio
3.4.1 Global Mucosolvan (Ambroxol) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mucosolvan (Ambroxol) Revenue in 2020
3.5 Mucosolvan (Ambroxol) Key Players Head office and Area Served
3.6 Key Players Mucosolvan (Ambroxol) Product Solution and Service
3.7 Date of Enter into Mucosolvan (Ambroxol) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mucosolvan (Ambroxol) Breakdown Data by Type
4.1 Global Mucosolvan (Ambroxol) Historic Market Size by Type (2016-2021)
4.2 Global Mucosolvan (Ambroxol) Forecasted Market Size by Type (2022-2027)
5 Mucosolvan (Ambroxol) Breakdown Data by Application
5.1 Global Mucosolvan (Ambroxol) Historic Market Size by Application (2016-2021)
5.2 Global Mucosolvan (Ambroxol) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Mucosolvan (Ambroxol) Market Size (2016-2027)
6.2 North America Mucosolvan (Ambroxol) Market Size by Type
6.2.1 North America Mucosolvan (Ambroxol) Market Size by Type (2016-2021)
6.2.2 North America Mucosolvan (Ambroxol) Market Size by Type (2022-2027)
6.2.3 North America Mucosolvan (Ambroxol) Market Size by Type (2016-2027)
6.3 North America Mucosolvan (Ambroxol) Market Size by Application
6.3.1 North America Mucosolvan (Ambroxol) Market Size by Application (2016-2021)
6.3.2 North America Mucosolvan (Ambroxol) Market Size by Application (2022-2027)
6.3.3 North America Mucosolvan (Ambroxol) Market Size by Application (2016-2027)
6.4 North America Mucosolvan (Ambroxol) Market Size by Country
6.4.1 North America Mucosolvan (Ambroxol) Market Size by Country (2016-2021)
6.4.2 North America Mucosolvan (Ambroxol) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Mucosolvan (Ambroxol) Market Size (2016-2027)
7.2 Europe Mucosolvan (Ambroxol) Market Size by Type
7.2.1 Europe Mucosolvan (Ambroxol) Market Size by Type (2016-2021)
7.2.2 Europe Mucosolvan (Ambroxol) Market Size by Type (2022-2027)
7.2.3 Europe Mucosolvan (Ambroxol) Market Size by Type (2016-2027)
7.3 Europe Mucosolvan (Ambroxol) Market Size by Application
7.3.1 Europe Mucosolvan (Ambroxol) Market Size by Application (2016-2021)
7.3.2 Europe Mucosolvan (Ambroxol) Market Size by Application (2022-2027)
7.3.3 Europe Mucosolvan (Ambroxol) Market Size by Application (2016-2027)
7.4 Europe Mucosolvan (Ambroxol) Market Size by Country
7.4.1 Europe Mucosolvan (Ambroxol) Market Size by Country (2016-2021)
7.4.2 Europe Mucosolvan (Ambroxol) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Mucosolvan (Ambroxol) Market Size (2016-2027)
8.2 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Type
8.2.1 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Type (2016-2027)
8.3 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Application
8.3.1 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Application (2016-2027)
8.4 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Region
8.4.1 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mucosolvan (Ambroxol) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mucosolvan (Ambroxol) Market Size (2016-2027)
9.2 Latin America Mucosolvan (Ambroxol) Market Size by Type
9.2.1 Latin America Mucosolvan (Ambroxol) Market Size by Type (2016-2021)
9.2.2 Latin America Mucosolvan (Ambroxol) Market Size by Type (2022-2027)
9.2.3 Latin America Mucosolvan (Ambroxol) Market Size by Type (2016-2027)
9.3 Latin America Mucosolvan (Ambroxol) Market Size by Application
9.3.1 Latin America Mucosolvan (Ambroxol) Market Size by Application (2016-2021)
9.3.2 Latin America Mucosolvan (Ambroxol) Market Size by Application (2022-2027)
9.3.3 Latin America Mucosolvan (Ambroxol) Market Size by Application (2016-2027)
9.4 Latin America Mucosolvan (Ambroxol) Market Size by Country
9.4.1 Latin America Mucosolvan (Ambroxol) Market Size by Country (2016-2021)
9.4.2 Latin America Mucosolvan (Ambroxol) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mucosolvan (Ambroxol) Market Size (2016-2027)
10.2 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Type
10.2.1 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Type (2016-2027)
10.3 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Application
10.3.1 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Application (2016-2027)
10.4 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Country
10.4.1 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mucosolvan (Ambroxol) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Zywie LLC
11.1.1 Zywie LLC Company Details
11.1.2 Zywie LLC Business Overview
11.1.3 Zywie LLC Mucosolvan (Ambroxol) Introduction
11.1.4 Zywie LLC Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.1.5 Zywie LLC Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Mucosolvan (Ambroxol) Introduction
11.2.4 Sanofi Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Hanmi
11.3.1 Hanmi Company Details
11.3.2 Hanmi Business Overview
11.3.3 Hanmi Mucosolvan (Ambroxol) Introduction
11.3.4 Hanmi Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.3.5 Hanmi Recent Development
11.4 Adare Pharma
11.4.1 Adare Pharma Company Details
11.4.2 Adare Pharma Business Overview
11.4.3 Adare Pharma Mucosolvan (Ambroxol) Introduction
11.4.4 Adare Pharma Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.4.5 Adare Pharma Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Mucosolvan (Ambroxol) Introduction
11.5.4 Boehringer Ingelheim Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teijin
11.6.1 Teijin Company Details
11.6.2 Teijin Business Overview
11.6.3 Teijin Mucosolvan (Ambroxol) Introduction
11.6.4 Teijin Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.6.5 Teijin Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Details
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Mucosolvan (Ambroxol) Introduction
11.7.4 Astellas Pharma Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.7.5 Astellas Pharma Recent Development
11.8 Chiesi
11.8.1 Chiesi Company Details
11.8.2 Chiesi Business Overview
11.8.3 Chiesi Mucosolvan (Ambroxol) Introduction
11.8.4 Chiesi Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.8.5 Chiesi Recent Development
11.9 Sidus
11.9.1 Sidus Company Details
11.9.2 Sidus Business Overview
11.9.3 Sidus Mucosolvan (Ambroxol) Introduction
11.9.4 Sidus Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.9.5 Sidus Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Mucosolvan (Ambroxol) Introduction
11.10.4 Takeda Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.10.5 Takeda Recent Development
11.11 Euderma
11.11.1 Euderma Company Details
11.11.2 Euderma Business Overview
11.11.3 Euderma Mucosolvan (Ambroxol) Introduction
11.11.4 Euderma Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.11.5 Euderma Recent Development
11.12 Changzhou Siyao Pharmaceuticals
11.12.1 Changzhou Siyao Pharmaceuticals Company Details
11.12.2 Changzhou Siyao Pharmaceuticals Business Overview
11.12.3 Changzhou Siyao Pharmaceuticals Mucosolvan (Ambroxol) Introduction
11.12.4 Changzhou Siyao Pharmaceuticals Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.12.5 Changzhou Siyao Pharmaceuticals Recent Development
11.13 Shandong Fangming Pharmaceutical Group
11.13.1 Shandong Fangming Pharmaceutical Group Company Details
11.13.2 Shandong Fangming Pharmaceutical Group Business Overview
11.13.3 Shandong Fangming Pharmaceutical Group Mucosolvan (Ambroxol) Introduction
11.13.4 Shandong Fangming Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.13.5 Shandong Fangming Pharmaceutical Group Recent Development
11.14 TIPR Pharmaceutical
11.14.1 TIPR Pharmaceutical Company Details
11.14.2 TIPR Pharmaceutical Business Overview
11.14.3 TIPR Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.14.4 TIPR Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.14.5 TIPR Pharmaceutical Recent Development
11.15 Hainan Weikang Pharmaceutical
11.15.1 Hainan Weikang Pharmaceutical Company Details
11.15.2 Hainan Weikang Pharmaceutical Business Overview
11.15.3 Hainan Weikang Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.15.4 Hainan Weikang Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.15.5 Hainan Weikang Pharmaceutical Recent Development
11.16 Sandoz (Novartis)
11.16.1 Sandoz (Novartis) Company Details
11.16.2 Sandoz (Novartis) Business Overview
11.16.3 Sandoz (Novartis) Mucosolvan (Ambroxol) Introduction
11.16.4 Sandoz (Novartis) Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.16.5 Sandoz (Novartis) Recent Development
11.17 Sinopharm
11.17.1 Sinopharm Company Details
11.17.2 Sinopharm Business Overview
11.17.3 Sinopharm Mucosolvan (Ambroxol) Introduction
11.17.4 Sinopharm Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.17.5 Sinopharm Recent Development
11.18 Jiangsu Hengrui Pharmaceutical
11.18.1 Jiangsu Hengrui Pharmaceutical Company Details
11.18.2 Jiangsu Hengrui Pharmaceutical Business Overview
11.18.3 Jiangsu Hengrui Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.18.4 Jiangsu Hengrui Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.18.5 Jiangsu Hengrui Pharmaceutical Recent Development
11.18 Yantai Dongcheng Dayang Pharmaceutical
11.25.1 Yantai Dongcheng Dayang Pharmaceutical Company Details
11.25.2 Yantai Dongcheng Dayang Pharmaceutical Business Overview
11.25.3 Yantai Dongcheng Dayang Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.25.4 Yantai Dongcheng Dayang Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.25.5 Yantai Dongcheng Dayang Pharmaceutical Recent Development
11.20 Zhuhai Tongyuan Pharmaceutical
11.20.1 Zhuhai Tongyuan Pharmaceutical Company Details
11.20.2 Zhuhai Tongyuan Pharmaceutical Business Overview
11.20.3 Zhuhai Tongyuan Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.20.4 Zhuhai Tongyuan Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.20.5 Zhuhai Tongyuan Pharmaceutical Recent Development
11.21 Beijing Taiyang Pharmaceutical
11.21.1 Beijing Taiyang Pharmaceutical Company Details
11.21.2 Beijing Taiyang Pharmaceutical Business Overview
11.21.3 Beijing Taiyang Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.21.4 Beijing Taiyang Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.21.5 Beijing Taiyang Pharmaceutical Recent Development
11.22 Nanjing Yihua Pharmaceutical
11.22.1 Nanjing Yihua Pharmaceutical Company Details
11.22.2 Nanjing Yihua Pharmaceutical Business Overview
11.22.3 Nanjing Yihua Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.22.4 Nanjing Yihua Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.22.5 Nanjing Yihua Pharmaceutical Recent Development
11.23 Shandong Luoxin Pharmaceutical Group
11.23.1 Shandong Luoxin Pharmaceutical Group Company Details
11.23.2 Shandong Luoxin Pharmaceutical Group Business Overview
11.23.3 Shandong Luoxin Pharmaceutical Group Mucosolvan (Ambroxol) Introduction
11.23.4 Shandong Luoxin Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.23.5 Shandong Luoxin Pharmaceutical Group Recent Development
11.24 Shandong Yuxin Pharmaceutical
11.24.1 Shandong Yuxin Pharmaceutical Company Details
11.24.2 Shandong Yuxin Pharmaceutical Business Overview
11.24.3 Shandong Yuxin Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.24.4 Shandong Yuxin Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.24.5 Shandong Yuxin Pharmaceutical Recent Development
11.25 CSPC
11.25.1 CSPC Company Details
11.25.2 CSPC Business Overview
11.25.3 CSPC Mucosolvan (Ambroxol) Introduction
11.25.4 CSPC Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.25.5 CSPC Recent Development
11.26 Shanxi Qianyuan Pharmaceutical Group
11.26.1 Shanxi Qianyuan Pharmaceutical Group Company Details
11.26.2 Shanxi Qianyuan Pharmaceutical Group Business Overview
11.26.3 Shanxi Qianyuan Pharmaceutical Group Mucosolvan (Ambroxol) Introduction
11.26.4 Shanxi Qianyuan Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.26.5 Shanxi Qianyuan Pharmaceutical Group Recent Development
11.27 Yangtze Pharmaceutical Group
11.27.1 Yangtze Pharmaceutical Group Company Details
11.27.2 Yangtze Pharmaceutical Group Business Overview
11.27.3 Yangtze Pharmaceutical Group Mucosolvan (Ambroxol) Introduction
11.27.4 Yangtze Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.27.5 Yangtze Pharmaceutical Group Recent Development
11.28 Jiangsu Aosaikang Pharmaceutical
11.28.1 Jiangsu Aosaikang Pharmaceutical Company Details
11.28.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.28.3 Jiangsu Aosaikang Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.28.4 Jiangsu Aosaikang Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.28.5 Jiangsu Aosaikang Pharmaceutical Recent Development
11.29 Jiangsu Haosen Pharmaceutical Group
11.29.1 Jiangsu Haosen Pharmaceutical Group Company Details
11.29.2 Jiangsu Haosen Pharmaceutical Group Business Overview
11.29.3 Jiangsu Haosen Pharmaceutical Group Mucosolvan (Ambroxol) Introduction
11.29.4 Jiangsu Haosen Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.29.5 Jiangsu Haosen Pharmaceutical Group Recent Development
11.30 Shenyang Xinma Pharmaceutical
11.30.1 Shenyang Xinma Pharmaceutical Company Details
11.30.2 Shenyang Xinma Pharmaceutical Business Overview
11.30.3 Shenyang Xinma Pharmaceutical Mucosolvan (Ambroxol) Introduction
11.30.4 Shenyang Xinma Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021)
11.30.5 Shenyang Xinma Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Mucosolvan (Ambroxol) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Capsules
Table 4. Key Players of Injections
Table 5. Key Players of Solutions
Table 6. Key Players of Syrups
Table 7. Key Players of Granules
Table 8. Global Mucosolvan (Ambroxol) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Mucosolvan (Ambroxol) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Mucosolvan (Ambroxol) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Mucosolvan (Ambroxol) Market Share by Regions (2016-2021)
Table 12. Global Mucosolvan (Ambroxol) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Mucosolvan (Ambroxol) Market Share by Regions (2022-2027)
Table 14. Mucosolvan (Ambroxol) Market Trends
Table 15. Mucosolvan (Ambroxol) Market Drivers
Table 16. Mucosolvan (Ambroxol) Market Challenges
Table 17. Mucosolvan (Ambroxol) Market Restraints
Table 18. Global Mucosolvan (Ambroxol) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Mucosolvan (Ambroxol) Market Share by Players (2016-2021)
Table 20. Global Top Mucosolvan (Ambroxol) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucosolvan (Ambroxol) as of 2020)
Table 21. Ranking of Global Top Mucosolvan (Ambroxol) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Mucosolvan (Ambroxol) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Mucosolvan (Ambroxol) Product Solution and Service
Table 25. Date of Enter into Mucosolvan (Ambroxol) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Mucosolvan (Ambroxol) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Mucosolvan (Ambroxol) Revenue Market Share by Type (2016-2021)
Table 29. Global Mucosolvan (Ambroxol) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Mucosolvan (Ambroxol) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Mucosolvan (Ambroxol) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Mucosolvan (Ambroxol) Revenue Market Share by Application (2016-2021)
Table 33. Global Mucosolvan (Ambroxol) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Mucosolvan (Ambroxol) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Mucosolvan (Ambroxol) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Mucosolvan (Ambroxol) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Mucosolvan (Ambroxol) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Mucosolvan (Ambroxol) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Mucosolvan (Ambroxol) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Mucosolvan (Ambroxol) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Mucosolvan (Ambroxol) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Mucosolvan (Ambroxol) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Mucosolvan (Ambroxol) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Mucosolvan (Ambroxol) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Mucosolvan (Ambroxol) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Mucosolvan (Ambroxol) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Mucosolvan (Ambroxol) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Mucosolvan (Ambroxol) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Mucosolvan (Ambroxol) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Mucosolvan (Ambroxol) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Mucosolvan (Ambroxol) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Mucosolvan (Ambroxol) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Mucosolvan (Ambroxol) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Mucosolvan (Ambroxol) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Mucosolvan (Ambroxol) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Mucosolvan (Ambroxol) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Mucosolvan (Ambroxol) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Mucosolvan (Ambroxol) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Mucosolvan (Ambroxol) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Mucosolvan (Ambroxol) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Mucosolvan (Ambroxol) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Mucosolvan (Ambroxol) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Mucosolvan (Ambroxol) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Mucosolvan (Ambroxol) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Zywie LLC Company Details
Table 66. Zywie LLC Business Overview
Table 67. Zywie LLC Mucosolvan (Ambroxol) Product
Table 68. Zywie LLC Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 69. Zywie LLC Recent Development
Table 70. Sanofi Company Details
Table 71. Sanofi Business Overview
Table 72. Sanofi Mucosolvan (Ambroxol) Product
Table 73. Sanofi Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 74. Sanofi Recent Development
Table 75. Hanmi Company Details
Table 76. Hanmi Business Overview
Table 77. Hanmi Mucosolvan (Ambroxol) Product
Table 78. Hanmi Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 79. Hanmi Recent Development
Table 80. Adare Pharma Company Details
Table 81. Adare Pharma Business Overview
Table 82. Adare Pharma Mucosolvan (Ambroxol) Product
Table 83. Adare Pharma Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 84. Adare Pharma Recent Development
Table 85. Boehringer Ingelheim Company Details
Table 86. Boehringer Ingelheim Business Overview
Table 87. Boehringer Ingelheim Mucosolvan (Ambroxol) Product
Table 88. Boehringer Ingelheim Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 89. Boehringer Ingelheim Recent Development
Table 90. Teijin Company Details
Table 91. Teijin Business Overview
Table 92. Teijin Mucosolvan (Ambroxol) Product
Table 93. Teijin Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 94. Teijin Recent Development
Table 95. Astellas Pharma Company Details
Table 96. Astellas Pharma Business Overview
Table 97. Astellas Pharma Mucosolvan (Ambroxol) Product
Table 98. Astellas Pharma Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 99. Astellas Pharma Recent Development
Table 100. Chiesi Company Details
Table 101. Chiesi Business Overview
Table 102. Chiesi Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 103. Chiesi Recent Development
Table 104. Sidus Company Details
Table 105. Sidus Business Overview
Table 106. Sidus Mucosolvan (Ambroxol) Product
Table 107. Sidus Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 108. Sidus Recent Development
Table 109. Takeda Company Details
Table 110. Takeda Business Overview
Table 111. Takeda Mucosolvan (Ambroxol) Product
Table 112. Takeda Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 113. Takeda Recent Development
Table 114. Euderma Company Details
Table 115. Euderma Business Overview
Table 116. Euderma Mucosolvan (Ambroxol) Product
Table 117. Euderma Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 118. Euderma Recent Development
Table 119. Changzhou Siyao Pharmaceuticals Company Details
Table 120. Changzhou Siyao Pharmaceuticals Business Overview
Table 121. Changzhou Siyao Pharmaceuticals Mucosolvan (Ambroxol) Product
Table 122. Changzhou Siyao Pharmaceuticals Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 123. Changzhou Siyao Pharmaceuticals Recent Development
Table 124. Shandong Fangming Pharmaceutical Group Company Details
Table 125. Shandong Fangming Pharmaceutical Group Business Overview
Table 126. Shandong Fangming Pharmaceutical Group Mucosolvan (Ambroxol) Product
Table 127. Shandong Fangming Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 128. Shandong Fangming Pharmaceutical Group Recent Development
Table 129. TIPR Pharmaceutical Company Details
Table 130. TIPR Pharmaceutical Business Overview
Table 131. TIPR Pharmaceutical Mucosolvan (Ambroxol) Product
Table 132. TIPR Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 133. TIPR Pharmaceutical Recent Development
Table 134. Hainan Weikang Pharmaceutical Company Details
Table 135. Hainan Weikang Pharmaceutical Business Overview
Table 136. Hainan Weikang Pharmaceutical Mucosolvan (Ambroxol) Product
Table 137. Hainan Weikang Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 138. Hainan Weikang Pharmaceutical Recent Development
Table 139. Sandoz (Novartis) Company Details
Table 140. Sandoz (Novartis) Business Overview
Table 141. Sandoz (Novartis) Mucosolvan (Ambroxol) Product
Table 142. Sandoz (Novartis) Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 143. Sandoz (Novartis) Recent Development
Table 144. Sinopharm Company Details
Table 145. Sinopharm Business Overview
Table 146. Sinopharm Mucosolvan (Ambroxol) Product
Table 147. Sinopharm Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 148. Sinopharm Recent Development
Table 149. Jiangsu Hengrui Pharmaceutical Company Details
Table 150. Jiangsu Hengrui Pharmaceutical Business Overview
Table 151. Jiangsu Hengrui Pharmaceutical Mucosolvan (Ambroxol) Product
Table 152. Jiangsu Hengrui Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 153. Jiangsu Hengrui Pharmaceutical Recent Development
Table 154. Yantai Dongcheng Dayang Pharmaceutical Company Details
Table 155. Yantai Dongcheng Dayang Pharmaceutical Business Overview
Table 156. Yantai Dongcheng Dayang Pharmaceutical Mucosolvan (Ambroxol) Product
Table 157. Yantai Dongcheng Dayang Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 158. Yantai Dongcheng Dayang Pharmaceutical Recent Development
Table 159. Zhuhai Tongyuan Pharmaceutical Company Details
Table 160. Zhuhai Tongyuan Pharmaceutical Business Overview
Table 161. Zhuhai Tongyuan Pharmaceutical Mucosolvan (Ambroxol) Product
Table 162. Zhuhai Tongyuan Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 163. Zhuhai Tongyuan Pharmaceutical Recent Development
Table 164. Beijing Taiyang Pharmaceutical Company Details
Table 165. Beijing Taiyang Pharmaceutical Business Overview
Table 166. Beijing Taiyang Pharmaceutical Mucosolvan (Ambroxol) Product
Table 167. Beijing Taiyang Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 168. Beijing Taiyang Pharmaceutical Recent Development
Table 169. Nanjing Yihua Pharmaceutical Company Details
Table 170. Nanjing Yihua Pharmaceutical Business Overview
Table 171. Nanjing Yihua Pharmaceutical Mucosolvan (Ambroxol) Product
Table 172. Nanjing Yihua Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 173. Nanjing Yihua Pharmaceutical Recent Development
Table 174. Shandong Luoxin Pharmaceutical Group Company Details
Table 175. Shandong Luoxin Pharmaceutical Group Business Overview
Table 176. Shandong Luoxin Pharmaceutical Group Mucosolvan (Ambroxol) Product
Table 177. Shandong Luoxin Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 178. Shandong Luoxin Pharmaceutical Group Recent Development
Table 179. Shandong Yuxin Pharmaceutical Company Details
Table 180. Shandong Yuxin Pharmaceutical Business Overview
Table 181. Shandong Yuxin Pharmaceutical Mucosolvan (Ambroxol)Product
Table 182. Shandong Yuxin Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 183. Shandong Yuxin Pharmaceutical Recent Development
Table 184. CSPC Company Details
Table 185. CSPC Business Overview
Table 186. CSPC Mucosolvan (Ambroxol) Product
Table 187. CSPC Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 188. CSPC Recent Development
Table 189. Shanxi Qianyuan Pharmaceutical Group Company Details
Table 190. Shanxi Qianyuan Pharmaceutical Group Business Overview
Table 191. Shanxi Qianyuan Pharmaceutical Group Mucosolvan (Ambroxol) Product
Table 192. Shanxi Qianyuan Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 193. Shanxi Qianyuan Pharmaceutical Group Recent Development
Table 194. Yangtze Pharmaceutical Group Company Details
Table 195. Yangtze Pharmaceutical Group Business Overview
Table 196. Yangtze Pharmaceutical Group Mucosolvan (Ambroxol) Product
Table 197. Yangtze Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 198. Yangtze Pharmaceutical Group Recent Development
Table 199. Jiangsu Aosaikang Pharmaceutical Company Details
Table 200. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 201. Jiangsu Aosaikang Pharmaceutical Mucosolvan (Ambroxol) Product
Table 202. Jiangsu Aosaikang Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 203. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 204. Jiangsu Haosen Pharmaceutical Group Company Details
Table 205. Jiangsu Haosen Pharmaceutical Group Business Overview
Table 206. Jiangsu Haosen Pharmaceutical Group Mucosolvan (Ambroxol) Product
Table 207. Jiangsu Haosen Pharmaceutical Group Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 208. Jiangsu Haosen Pharmaceutical Group Recent Development
Table 209. Shenyang Xinma Pharmaceutical Company Details
Table 210. Shenyang Xinma Pharmaceutical Business Overview
Table 211. Shenyang Xinma Pharmaceutical Mucosolvan (Ambroxol) Product
Table 212. Shenyang Xinma Pharmaceutical Revenue in Mucosolvan (Ambroxol) Business (2016-2021) & (US$ Million)
Table 213. Shenyang Xinma Pharmaceutical Recent Development
Table 214. Research Programs/Design for This Report
Table 215. Key Data Information from Secondary Sources
Table 216. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mucosolvan (Ambroxol) Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Capsules Features
Figure 4. Injections Features
Figure 5. Solutions Features
Figure 6. Syrups Features
Figure 7. Granules Features
Figure 8. Global Mucosolvan (Ambroxol) Market Share by Application: 2020 VS 2027
Figure 9. Acute And Chronic Bronchitis Case Studies
Figure 10. Bronchial Asthma Case Studies
Figure 11. Bronchiectasis Case Studies
Figure 12. Emphysema Case Studies
Figure 13. Tuberculosis (TB) Case Studies
Figure 14. Pneumoconiosis Case Studies
Figure 15. Postoperative Medication Case Studies
Figure 16. Other Case Studies
Figure 17. Mucosolvan (Ambroxol) Report Years Considered
Figure 18. Global Mucosolvan (Ambroxol) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Mucosolvan (Ambroxol) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Mucosolvan (Ambroxol) Market Share by Regions: 2020 VS 2027
Figure 21. Global Mucosolvan (Ambroxol) Market Share by Regions (2022-2027)
Figure 22. Global Mucosolvan (Ambroxol) Market Share by Players in 2020
Figure 23. Global Top Mucosolvan (Ambroxol) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucosolvan (Ambroxol) as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Mucosolvan (Ambroxol) Revenue in 2020
Figure 25. Global Mucosolvan (Ambroxol) Revenue Market Share by Type (2016-2021)
Figure 26. Global Mucosolvan (Ambroxol) Revenue Market Share by Type (2022-2027)
Figure 27. North America Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Mucosolvan (Ambroxol) Market Share by Type (2016-2027)
Figure 29. North America Mucosolvan (Ambroxol) Market Share by Application (2016-2027)
Figure 30. North America Mucosolvan (Ambroxol) Market Share by Country (2016-2027)
Figure 31. United States Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Mucosolvan (Ambroxol) Market Share by Type (2016-2027)
Figure 35. Europe Mucosolvan (Ambroxol) Market Share by Application (2016-2027)
Figure 36. Europe Mucosolvan (Ambroxol) Market Share by Country (2016-2027)
Figure 37. Germany Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Mucosolvan (Ambroxol) Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Mucosolvan (Ambroxol) Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Mucosolvan (Ambroxol) Market Share by Region (2016-2027)
Figure 47. China Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Mucosolvan (Ambroxol) Market Share by Type (2016-2027)
Figure 55. Latin America Mucosolvan (Ambroxol) Market Share by Application (2016-2027)
Figure 56. Latin America Mucosolvan (Ambroxol) Market Share by Country (2016-2027)
Figure 57. Mexico Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Mucosolvan (Ambroxol) Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Mucosolvan (Ambroxol) Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Mucosolvan (Ambroxol) Market Share by Country (2016-2027)
Figure 63. Turkey Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Mucosolvan (Ambroxol) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Zywie LLC Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 68. Hanmi Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 69. Adare Pharma Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 70. Boehringer Ingelheim Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 71. Teijin Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 72. Astellas Pharma Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 73. Chiesi Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 74. Sidus Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 75. Takeda Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 76. Euderma Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 77. Changzhou Siyao Pharmaceuticals Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 78. Shandong Fangming Pharmaceutical Group Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 79. TIPR Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 80. Hainan Weikang Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 81. Sandoz (Novartis) Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 82. Sinopharm Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 83. Jiangsu Hengrui Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 84. Yantai Dongcheng Dayang Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 85. Zhuhai Tongyuan Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 86. Beijing Taiyang Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 87. Nanjing Yihua Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 88. Shandong Luoxin Pharmaceutical Group Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 89. Shandong Yuxin Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 90. CSPC Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 91. Shanxi Qianyuan Pharmaceutical Group Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 92. Yangtze Pharmaceutical Group Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 93. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 94. Jiangsu Haosen Pharmaceutical Group Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 95. Shenyang Xinma Pharmaceutical Revenue Growth Rate in Mucosolvan (Ambroxol) Business (2016-2021)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
世界の急性・慢性異常子宮出血（AUB）市場規模・現状・予測（2021年-2027年） Abnormal uterine bleeding (AUB) may be acute or chronic and is defined as bleeding from the uterine corpus that is abnormal in regularity, volume, frequency, or duration and occurs in the absence of pregnancy. Market Analysis and Insights: Global Acute and Chronic Abnormal Uterine Bleeding Market Th…- 世界のじん肺症市場規模・現状・予測（2021年-2027年） Pneumoconiosis is an occupational lung disease and a restrictive lung disease caused by the inhalation of dust, often in mines and from agriculture. In 2013 pneumoconiosis resulted in 260,000 deaths up from 251,000 deaths in 1990. Of these deaths 46,000 were due to silicosis, 24,000 due to asbestosi…
- 世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年） Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in seri…
- 世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年） Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in seri…
- 世界の肺気腫治療市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible. The major driving factor for emphysema treatment in global market is smoking habit of enormous population wo…